Our group previously showed that pharmacological depletion of DNMTs in lung cancer cells led to upregulation of multiple immune synaptic molecules by quantitative surface proteomics analysis, including MHC, stimulatory or inhibitory immune checkpoints, adhesion molecules, as well as ligands for MHC-unrestricted receptors of innate immune cells. This evidence concerns the gene HLA-C and lung cancer.